Премини към основното съдържание
Home
language-selector-globe Bulgaria | bg
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Bulgaria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • За нас 
      • Новартис в България 
      • Нашата стратегия 
        • Иновативни лекарства 
      • Хора и Култура 
      • Контакти 
      За нас За нас
    • Пациенти и болногледачи 
      • Аз само да попитам: твоят здравен консултант 
      • Ангажиментът на Новартис към пациентите и лицата, които се грижат за тях 
      • Съобщаване на нежелани реакции 
      • Аз само да попитам: твоят здравен портал 
      Пациенти и болногледачи Пациенти и болногледачи
    • Здравни специалисти 
      • Материали за здравни специалисти 
      • Новартис проекти 
      • Съобщаване на нежелани реакции 
      • Клинични проучвания на Новартис 
      Здравни специалисти Здравни специалисти
    • ESG 
      • Етика, Риск и Законосъобразност 
      • Разширяване на достъпа до здравеопазване 
      • Опазване на природата 
      • Световно здраве 
      • Етично поведение 
        • Етичен кодекс 
        • SpeakUp 
      Околна среда, социални и правни въпроси ESG
    • Новини 
      • Медийни контакти 
      • Новини 
      Новини Новини
    • Кариера 
      • Търсене на кариера 
      • Награди и признание 
      Кариера Кариера
    • Коронавирус 
      Коронавирус Коронавирус
    Новартис България Начало
  1. Начало
  2. Кариера
  3. Търсене на кариера
  • Sort by Sort ascending
  • Длъжност
  • Място
  • Местоположение
  • дивизия Sort descending
  • Бизнес
  • Functional Area
  • Дата
Длъжност Място Местоположение дивизия Sort descending Бизнес Functional Area Дата
GCP Inspection Project Manager London (The Westworks) United Kingdom Development Innovative Medicines Quality Окт. 16, 2024
Senior Expert Science & Technology, Analytical Development East Hanover USA Development Innovative Medicines Research & Development Окт. 16, 2024
RA Operational Excellence Junior Associate – MEA Dubai Utd.Arab Emir. Development Innovative Medicines Research & Development Окт. 16, 2024
Country Patient Safety Head - France Paris Headquarter (Novartis Pharma S.A.S.) France Development Innovative Medicines Research & Development Окт. 17, 2024
Senior Expert Technical Development- Drug Product Project Lead East Hanover USA Development Innovative Medicines Research & Development Окт. 17, 2024
Vendor Alliance Lead Associate Director East Hanover USA Development Innovative Medicines Research & Development Окт. 17, 2024
Global Program Safety Lead - Immunology Basel (City) Switzerland Development Innovative Medicines Research & Development Окт. 17, 2024
Global Program Safety Lead - Immunology London (The Westworks) United Kingdom Development Sandoz Research & Development Окт. 17, 2024
Strategy Director, Clinical Development Basel (City) Switzerland Development Innovative Medicines Research & Development Окт. 17, 2024
Senior Clinical Research Associate (Remote) Field Non-Sales (USA) USA Development Innovative Medicines Research & Development Окт. 17, 2024
Senior Principal Clinical Data Standards Specialist Mumbai (Office) India Development Innovative Medicines Research & Development Окт. 18, 2024
Medical Safety and Processes Manager Barcelona Gran Vía Spain Development Innovative Medicines Research & Development Окт. 18, 2024
Study Start Up Senior Lead Dublin (Novartis Corporate Center (NOCC)) Ireland Development Innovative Medicines Research & Development Окт. 18, 2024
RA Specialist Croatia Croatia Development Innovative Medicines Research & Development Окт. 18, 2024
Director of Patient-Centered Outcomes London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Окт. 18, 2024
Gerente de Operações Estratégicas e Compliance Jr. Santo Amaro Brazil Development Innovative Medicines Research & Development Окт. 18, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Окт. 09, 2024
Feasibility Manager INSURGENTES Mexico Development Innovative Medicines Research & Development Окт. 16, 2024
Patient Safety Manager Paris Headquarter (Novartis Pharma S.A.S.) France Development Innovative Medicines Research & Development Септ. 04, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Окт. 09, 2024
Clinical Research Associate Field Force (Italy) Italy Development Innovative Medicines Research & Development Окт. 16, 2024
Clinical Biospecimen Senior Scientist Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Септ. 03, 2024
Senior Statistical Programmer Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Юли 18, 2024
Study Leader Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Септ. 05, 2024
Associate Clinical Project Manager Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Окт. 18, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Окт. 09, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Окт. 09, 2024
Expert Science & Technology Changshu (Jiangsu Province) China Development Innovative Medicines Research & Development Септ. 03, 2024
Regulatory Affairs Manager Beijing (Beijing) China Development Innovative Medicines Research & Development Септ. 01, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Окт. 09, 2024
Associate Director ERC Risk&Operations, Corporate Functions Selangor Malaysia Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compl. Авг. 29, 2024
Ethics, Risk & Compliance Manager Selangor Malaysia Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Авг. 22, 2024
Manager- Data Privacy Review and Remediation Telangana India Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compl. Окт. 10, 2024
Associate Director, Data Privacy, Digital & AI East Hanover USA Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compl. Септ. 04, 2024
Sr Manager/Manager-Monitoring Shanghai (Shanghai) China Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Юли 18, 2024
Head DPDAI China Shanghai (Shanghai) China Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Окт. 14, 2024
Manager- Data Privacy Review and Remediation Selangor Malaysia Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compl. Окт. 14, 2024
Associate Director - Risk & Assurance, EUROPE Prague Czech Republic Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Окт. 11, 2024
Risk & Assurance Manager Mumbai (Head Office) India Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Окт. 16, 2024
Country ERC Head, India Mumbai (Office) India Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Окт. 16, 2024
P2P & T&E Specialist (Japanese speaker) Selangor Malaysia Finance CTS Audit & Finance Юни 05, 2024
P2P & T&E Business Partner (Japanese speaker) Selangor Malaysia Finance CTS Audit & Finance Юни 12, 2024
R2R Senior Specialist GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Юни 13, 2024
Global Digital FRA Automation Lead Hyderabad (Office) India Finance Corporate Audit & Finance Юни 20, 2024
FP&A Manager İstanbul Kavacık Turkey Finance Innovative Medicines Audit & Finance Юни 28, 2024
Senior Financial Reporting and Accounting Specialist Prague Czech Republic Finance CTS Audit & Finance Юли 03, 2024
P2P & T&E Specialist (Arabic Speaker) Selangor Malaysia Finance CTS Audit & Finance Юли 05, 2024
Tax Specialist (m/w/d) Schaftenau Austria Finance CTS Audit & Finance Юли 22, 2024
Tax Manager m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany Finance Corporate Audit & Finance Окт. 16, 2024
ERP Assurance Senior Consultant-2 INSURGENTES Mexico Finance CTS Audit & Finance Авг. 20, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 42
  • › Next page

Новартис България

Навигация
  • Пациенти и болногледачи
  • Здравни специалисти
  • ESG
  • Новини
  • Кариера
Медиен център
  • Архив
  • Новини
Нашето портфолио
  • Клинични проекти на Новартис
Други сайтове на Новартис
  • Глобален сайт
Footer Bottom
© 2024 Новартис АГ
  • Политика за поверителност
  • Условия на ползване
  • Достъп от мрежата
  • Настройки за бисквитки
  • Навигация на сайта
Директория на сайта на Новартис
Тази страница е предназначена за обществеността в България